A new self: MHC-class-I-independent Natural-killer-cell self-tolerance

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Nature reviews. Immunology

• Publication date

  2005-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nri1603PMID 15841099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2B4 (CD244) Is Expressed and Functional on Human Eosinophils1

  2005cited by this paper
• A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.

  2005cited by this paper
• Adhesion of human T cells to antigen-presenting cells through SIRPbeta2-CD47 interaction costimulates T-cell proliferation.

  2005cited by this paper
• NK cell recognition.

  2005cited by this paper
• 2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells.

  2005cited by this paper
• Targeted Disruption of the 2B4 Gene in Mice Reveals an In Vivo Role of 2B4 (CD244) in the Rejection of B16 Melanoma Cells1

  2005cited by this paper
• Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112).

  2005cited by this paper
• The LLT1 receptor induces IFN-γ production by human natural killer cells

  2004cited by this paper
• Cutting Edge: Innate Production of IFN-γ by NK Cells Is Independent of Epigenetic Modification of the IFN-γ Promoter1

  2004cited by this paper
• Detection of a Soluble Form of the Leukocyte Surface Antigen CD48 in Plasma and Its Elevation in Patients with Lymphoid Leukemias and Arthritis

  2004cited by this paper
• Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus.

  2004cited by this paper
• The Murine NK Receptor 2B4 (CD244) Exhibits Inhibitory Function Independent of Signaling Lymphocytic Activation Molecule-Associated Protein Expression1

  2004cited by this paper
• Specific Regulation of T Helper Cell 1–mediated Murine Colitis by CEACAM1

  2004cited by this paper
• Immune signalling in neural development, synaptic plasticity and disease

  2004cited by this paper
• An Evolutionary Perspective

  2004cited by this paper
• On the origins of adaptive immunity: innate immune receptors join the tale.

  2004cited by this paper
• 2B4 Acts As a Non–Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells

  2004cited by this paper
• Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation

  2004cited by this paper
• Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors.

  2004cited by this paper
• The murine inhibitory receptor mSiglec‐E is expressed broadly on cells of the innate immune system whereas mSiglec‐F is restricted to eosinophils

  2004cited by this paper
• The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients.

  2004cited by this paper
• The Critical Role of Residues 43R and 44Q of Carcinoembryonic Antigen Cell Adhesion Molecules-1 in the Protection from Killing by Human NK Cells1

  2004cited by this paper
• Human Lymphocytes Interact Directly with CD47 through a Novel Member of the Signal Regulatory Protein (SIRP) Family1

  2004cited by this paper
• Cutting Edge: Innate production of IFN-gamma by NK cells is independent of epigenetic modification of the IFN-gamma promoter.

  2004cited by this paper
• The LLT1 receptor induces IFN-gamma production by human natural killer cells.

  2004cited by this paper
• NK Cells Stimulate Proliferation of T and NK Cells through 2B4/CD48 Interactions1

  2004cited by this paper
• Negative Regulation of T Cell Receptor Signaling by Siglec-7 (p70/AIRM) and Siglec-9*

  2004cited by this paper
• Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?

  2004cited by this paper
• Biological function of the soluble CEACAM1 protein and implications in TAP2‐deficient patients

  2004cited by this paper
• The Membrane-Proximal Immunoreceptor Tyrosine-Based Inhibitory Motif Is Critical for the Inhibitory Signaling Mediated by Siglecs-7 and -9, CD33-Related Siglecs Expressed on Human Monocytes and NK Cells1

  2004cited by this paper
• The tumour suppressor gene CEACAM1 is completely but reversibly downregulated in renal cell carcinoma

  2004cited by this paper
• Immune functions encoded by the natural killer gene complex

  2003cited by this paper
• The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease

  2003cited by this paper
• Constitutive Cytokine mRNAs Mark Natural Killer (NK) and NK T Cells Poised for Rapid Effector Function

  2003cited by this paper
• Cutting Edge: The NK Cell Receptor 2B4 Augments Antigen-Specific T Cell Cytotoxicity Through CD48 Ligation on Neighboring T Cells1

  2003cited by this paper
• Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec‐7‐dependent and ‐independent mechanisms

  2003cited by this paper
• A novel cell‐binding mechanism of Moraxella catarrhalis ubiquitous surface protein UspA: specific targeting of the N‐domain of carcinoembryonic antigen‐related cell adhesion molecules by UspA1

  2003cited by this paper
• The gp49B1 Inhibitory Receptor Regulates the IFN-γ Responses of T Cells and NK Cells

  2003cited by this paper
• Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors

  2003cited by this paper
• The gp49B1 inhibitory receptor regulates the IFN-gamma responses of T cells and NK cells.

  2003cited by this paper
• CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease.

  2002cited by this paper
• Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases

  2002cited by this paper
• GD3 ganglioside and apoptosis.

  2002cited by this paper
• Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions

  2002cited by this paper
• Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective.

  2002cited by this paper
• A Ligand for the Murine NK Activation Receptor Ly-49D: Activation of Tolerized NK Cells from β2-Microglobulin- Deficient Mice1

  2002cited by this paper
• A Structurally Variant Form of the 2B4 Antigen Is Expressed on the Cell Surface of Mouse Mast Cells

  2002cited by this paper
• CD66a Interactions Between Human Melanoma and NK Cells: A Novel Class I MHC-Independent Inhibitory Mechanism of Cytotoxicity1

  2002cited by this paper
• CEACAM1: a marker with a difference or more of the same?

  2002cited by this paper
• Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibility

  2002cited by this paper
• Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation

  2002cited by this paper
• Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes

  2002cited by this paper
• Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors

  2002cited by this paper
• Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance.

  2002cited by this paper
• Cutting Edge: Inhibitory Functions of the Killer Cell Lectin-Like Receptor G1 Molecule During the Activation of Mouse NK Cells1

  2002cited by this paper
• Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells.

  2002cited by this paper
• Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation

  2002cited by this paper
• An unusual inhibitory receptor--the mast cell function-associated antigen (MAFA).

  2002cited by this paper
• Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Expression and Signaling in Human, Mouse, and Rat Leukocytes: Evidence for Replacement of the Short Cytoplasmic Domain Isoform by Glycosylphosphatidylinositol-Linked Proteins in Human Leukocytes1

  2002cited by this paper
• Chemical Diversity in the Sialic Acids and Related α-Keto Acids: An Evolutionary Perspective

  2002cited by this paper
• Inhibitory receptors and allergy.

  2002cited by this paper
• Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions.

  2002cited by this paper
• A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to alpha 2,8-disialyl and branched alpha 2,6-sialyl residues. A comparison with Siglec-9.

  2002cited by this paper
• The enemy within: keeping self-reactive T cells at bay in the periphery

  2002cited by this paper
• Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants

  2002cited by this paper
• Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

  2002cited by this paper
• Natural killer cells and pregnancy

  2002cited by this paper
• A Small Region of the Natural Killer Cell Receptor, Siglec-7, Is Responsible for Its Preferred Binding to α2,8-Disialyl and Branched α2,6-Sialyl Residues

  2002cited by this paper
• Cutting Edge: Regulation of CD8+ T Cell Proliferation by 2B4/CD48 Interactions1

  2001cited by this paper
• Cloning of Clr, a new family of lectin-like genes localized between mouse Nkrp1a and Cd69

  2001cited by this paper
• Binding specificity of siglec7 to disialogangliosides of renal cell carcinoma: possible role of disialogangliosides in tumor progression

  2001cited by this paper
• Cd47 (Integrin-Associated Protein) Engagement of Dendritic Cell and Macrophage Counterreceptors Is Required to Prevent the Clearance of Donor Lymphohematopoietic Cells

  2001cited by this paper
• 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes

  2001cited by this paper
• Identification and Characterization of a Spliced C-Type Lectin-Like Gene Encoded by Rat Cytomegalovirus

  2001cited by this paper
• Molecular Cloning of MIS, a Myeloid Inhibitory Siglec, That Binds Protein-tyrosine Phosphatases SHP-1 and SHP-2*

  2001cited by this paper
• Siglecs, sialic acids and innate immunity.

  2001cited by this paper
• Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 on Murine Dendritic Cells Is a Potent Regulator of T Cell Stimulation1

  2001cited by this paper
• gp49B1-αvβ3 interaction inhibits antigen-induced mast cell activation

  2001cited by this paper
• Regulation of the natural killer cell receptor repertoire.

  2001cited by this paper
• gp49B1-alpha(v)beta3 interaction inhibits antigen-induced mast cell activation.

  2001cited by this paper
• A Novel Osteoblast-derived C-type Lectin That Inhibits Osteoclast Formation*

  2001cited by this paper
• X-Linked Lymphoproliferative Disease

  2000cited by this paper
• Role of CD47 as a marker of self on red blood cells.

  2000cited by this paper
• Carcinoembryonic antigens are targeted by diverse strains of typable and non‐typable Haemophilus influenzae

  2000cited by this paper
• The Genome of Fowlpox Virus

  2000cited by this paper
• Natural Killer Cells and Mast Cells from gp49B Null Mutant Mice Are Functional

  2000cited by this paper
• NK cell expression of the killer cell lectin‐like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules

  2000cited by this paper
• Ly49I NK Cell Receptor Transgene Inhibition of Rejection of H2b Mouse Bone Marrow Transplants1 2

  2000cited by this paper
• Inducible Expression of the gp49B Inhibitory Receptor on NK Cells1

  2000cited by this paper
• Siglec-9, a Novel Sialic Acid Binding Member of the Immunoglobulin Superfamily Expressed Broadly on Human Blood Leukocytes*

  2000cited by this paper
• Cutting Edge: Functional Requirement for SAP in 2B4-Mediated Activation of Human Natural Killer Cells as Revealed by the X-Linked Lymphoproliferative Syndrome1

  2000cited by this paper
• Direct NK Cell-Mediated Lysis of Syngenic Dorsal Root Ganglia Neurons In Vitro1

  2000cited by this paper
• 2B4-mediated activation of human natural killer cells.

  2000cited by this paper
• Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation.

  1999cited by this paper
• An African swine fever virus ORF with similarity to C-type lectins is non-essential for growth in swine macrophages in vitro and for virus virulence in domestic swine.

  1999cited by this paper
• Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.

  1999cited by this paper
• The vaccinia virus A4OR gene product is a nonstructural, type II membrane glycoprotein that is expressed at the cell surface.

  1999cited by this paper
• Repressor Transcriptional Activator , LuxR , to a Vibrio fischeri Conversion of the

  1999cited by this paper
• The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues.

  1999cited by this paper
• The NKR-P1B gene product is an inhibitory receptor on SJL/J NK cells.

  1999cited by this paper

• Innate Immunity and Platelets: Unveiling Their Role in Chronic Pancreatitis and Pancreatic Cancer

  2025cites this paper
• Adoptive cell therapy for cancer: combination strategies and biomarkers

  2025cites this paper
• Mild Reduction‐Mediated NK Cell Membrane Modification for ROS Scavenging Efficacy Overcome Immunosuppressive Tumor Microenvironment

  2025cites this paper
• Advanced Polymeric Nanoparticles for Cancer Immunotherapy: Materials Engineering, Immunotherapeutic Mechanism and Clinical Translation

  2025cites this paper
• Precision therapeutic targets for HPV-positive cancers: an overview and new insights

  2025cites this paper
• Enhanced Natural Killer Cell Proliferation by Stress‐Induced Feeder Cells

  2025cites this paper
• Unraveling genome- and immunome-wide genetic diversity in modern and historical Jaguars

  2025cites this paper
• Protease regulation of tumor-immune cell symbiosis.

  2025cites this paper
• DNA scaffold framed natural killer cell with time programming payloads release for combined chemo-adoptive cell therapy.

  2025cites this paper
• E5 Oncoprotein: A Key Player in Human Papillomavirus-Positive Head and Neck Cancer Pathogenesis and Therapy Resistance

  2025cites this paper
• The Immune System—A Double-Edged Sword for Adenovirus-Based Therapies

  2024cites this paper
• Comparison of Natural Killer Cells Differentiated from Various Pluripotent Stem Cells

  2024cites this paper
• Recognition of Listeria monocytogenes infection by natural killer cells: Towards a complete picture by experimental studies in rats

  2023cites this paper
• Balancing act: the complex role of NK cells in immune regulation

  2023cites this paper
• RETRACTED ARTICLE: CTLA4-Ig alleviates the allogeneic immune responses against insulin-producing cells in a murine model of cell transplantation

  2023cites this paper
• Targeting cancer-associated glycans as a therapeutic strategy in leukemia

  2022cites this paper
• Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells

  2022influential citation
• Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis

  2022cites this paper
• Increased expression of TIGIT and KLRG1 correlates with impaired CD56bright NK cell immunity in HPV16-related cervical intraepithelial neoplasia

  2022cites this paper
• Targeting natural killer cells in cancer immunotherapy

  2022cites this paper
• The tricks for fighting against cancer using CAR NK cells: A review.

  2022cites this paper
• Increased Expression of TIGIT And KLRG1 Correlates With Impaired CD56Bright NK Cell Immunity In HPV16- Rrelated Cervical Intraepithelial Neoplasia

  2021cites this paper
• Rheumatoid Arthritis Susceptibility Is Associated with the KIR2DS4-Full of Killer-Cell Immunoglobulin-Like Receptor Genes in the Lur Population of Iran.

  2021cites this paper
• The Accidental Pathologist: A Curiosity-Driven Journey from Plant Evolution to Innate Immunity.

  2021cites this paper
• NK cell and ILC heterogeneity in colorectal cancer. New perspectives from high dimensional data.

  2021cites this paper
• Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C

  2021cites this paper
• Immunometabolic targeting of NK cells to solid tumors

  2021cites this paper
• Potential utility of melatonin in deadly infectious diseases related to the overreaction of innate immune response and destructive inflammation: focus on COVID-19

  2020cites this paper
• Crystal structures of lysophospholipid-bound MHC class I molecules

  2020cites this paper
• Maternal killer-cell immunoglobulin-like receptors and paternal human leukocyte antigen ligands in recurrent pregnancy loss cases in Turkey

  2020cites this paper
• Immunotherapy with NK cells: recent developments in gene modification open up new avenues

  2020cites this paper
• Regulation of MHC class I-independent NK cell education by SLAM family receptors.

  2020cites this paper
• Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer

  2020cites this paper
• IL‐21 reinvigorates exhausted natural killer cells in patients with HBV‐associated hepatocellular carcinoma in STAT1‐depedent pathway

  2019cites this paper
• Humoral alloimmunity in cardiac allograft rejection

  2019cites this paper
• Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy

  2019cites this paper
• Identificação dos mecanismos de regulação das células Natural Killer pelo fator de transcrição C/EBPG (CCAAT/enhancer binding protein gamma)

  2018cites this paper
• The yin‐yang of the interaction between myelomonocytic cells and NK cells

  2018cites this paper
• IL-1R8 : a novel checkpoint regulating anti-tumor and anti-viral activity of NK cells

  2018cites this paper
• Induced human pluripotent stem cell-derived NK cells as an alternative source of lymphocytes for anti-cancer immunotherapy

  2018cites this paper
• Reptilia: Cellular Immunity in Reptiles: Perspective on Elements of Evolution

  2018cites this paper
• Allogeneic Stem Cell Transplantation

  2018cites this paper
• The Inhibitory NKR-P1B:Clr-b Recognition Axis Facilitates Detection of Oncogenic Transformation and Cancer Immunosurveillance.

  2018cites this paper
• Humoral responses to Cytomegalovirus glycoprotein B vaccine with MF59 adjuvant

  2017cites this paper
• Roles for NK Cells and ILC1 in Inflammation and Infection

  2017cites this paper
• Immunological characterization of Cytomegalovirus-specific T cells and generation of HLA-C7- Strep Tamers for adoptive T cell therapy

  2017cites this paper
• Ligand binding and transmembranal signaling of the activating natural killer cell receptor NKp30

  2017cites this paper
• Leveraging natural killer cells for cancer immunotherapy.

  2017cites this paper
• IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours

  2017cites this paper
• Investigation of a NKG2D-dependent tumor immune escape mechanism of head and neck squamous cell carcinoma and proof of concept of a clinical intervention strategy

  2017cites this paper
• Natural killer cells as a promising tool to tackle cancer—A review of sources, methodologies, and potentials

  2017cites this paper
• Listeria monocytogenes infection differentially affects expression of ligands for NK cells and NK cell responses, depending on the cell type infected

  2016cites this paper
• The biology of mantle cell lymphoma : exploring the gender difference in mantle cell lymphoma

  2016cites this paper
• Natural Killer Cells: A Review on Their Role in Cancer Immunotherapy

  2016cites this paper
• NK Cells and Cancer Immunoediting.

  2016cites this paper
• Natural Killer Cells

  2016cites this paper
• Identifying and Targeting Immune Escape Mechanisms in Epstein-Barr Virus-Driven Lymphoproliferative Disease

  2016cites this paper
• Reduced Plasmodium Parasite Burden Associates with CD38+ CD4+ T Cells Displaying Cytolytic Potential and Impaired IFN-γ Production

  2016cites this paper
• Global and CMV-specific Immune Assays to Predict Clinical Outcomes and Inform Clinical Practice in Solid Organ Transplant Recipients

  2016cites this paper
• Modulation of Clr Ligand Expression and NKR-P1 Receptor Function during Murine Cytomegalovirus Infection

  2015cites this paper
• Natural Killer Cells: A Potential Therapy for Paediatric Brain Tumours

  2015influential citation
• Untersuchung von natürlichen Killerzellen in einem murinen NKG2D-Rezeptor-defizienten Spontan-Lymphommodell

  2015cites this paper
• Differential loss of natural killer cell activity in patients with acute myocardial infarction and stable angina pectoris.

  2015cites this paper
• Chemical Lectinology: Tools for Probing the Ligands and Dynamics of Mammalian Lectins In Vivo.

  2015cites this paper
• Investigating and harnessing T-cell functions with engineered immune receptors and their ligands

  2015influential citation
• TIGIT expression levels on human NK cells correlate with functional heterogeneity among healthy individuals

  2015cites this paper
• Le FCyRIIIa/CD16A des cellules Natural Killer (NK) humaines : régulation de son expression et variabilité des réponses fonctionnelles induites par son engagement

  2014influential citation
• Improving Hematopoietic Stem Cell Transplantation by Developing New Tools to Reduce Donor Cell Rejection

  2014cites this paper
• The role of Endoplasmic Reticulum Aminopeptidase 1(ERAP1) in Ankylosing Spondylitis

  2014cites this paper
• Siglec-mediated regulation of immune cell function in disease

  2014cites this paper
• Evaluation of the implication of KIR2DL2 receptor in multiple sclerosis and herpesvirus susceptibility.

  2014cites this paper
• Immunology: glyco-engineering 'super-self'.

  2014cites this paper
• NKG2D CARs as Cell Therapy for Cancer

  2014cites this paper
• Activating Killer Cell Ig-Like Receptors in Health and Disease

  2014cites this paper
• CD 47 : A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease

  2014cites this paper
• KIR-HLA combinations and susceptibility to tuberculosis

  2013cites this paper
• Mouse TIGIT inhibits NK‐cell cytotoxicity upon interaction with PVR

  2013cites this paper
• Étude génétique et fonctionnelle des Interferon-producing Killer Dendritic Cells

  2013cites this paper
• The role of coronin 1 during cell mediated immune responses

  2013cites this paper
• The effect of B2 agonists on the immune function

  2013cites this paper
• Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology

  2013cites this paper
• Re-Directing CD4+ T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not Enough

  2013cites this paper
• REGULATION FONCTIONNELLE DES CELLULES NATURAL KILLER PAR LE RECEPTEUR ACTIVATEUR NKP46

  2013cites this paper
• Genetic Investigation of MHC-independent Missing-self Recognition by NK Cells

  2013cites this paper
• Type I interferon regulation of natural killer cell function in primary and secondary infections

  2013cites this paper
• Characterization of the human NLR protein NLRC5

  2013cites this paper
• CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease

  2013cites this paper
• Host-specific innate and adaptive immune responses in therapy-naive human immunodeficiency virus 1 infected patients

  2013cites this paper
• Functionally Distinct NK Cell Subsets in Rats Ly49s3 Identify Two Complementary, The Novel Inhibitory NKR-P1C Receptor and

  2013cites this paper
• Natural Killer Cell and Cancer Immunotherapy

  2013cites this paper
• Molecular signatures of T-cell inhibition in HIV-1 infection

  2013cites this paper
• The role of balance between inhibitory and activating KIRs in determining susceptibility to Ankylosing Spondylitis

  2012cites this paper
• KLRB Receptor Family and Human Early Activation Antigen (CD69)

  2012cites this paper
• Modulation of Ly49A+ Natural Killer Cell Licensing by Major Histocompatibility Complex Class I Alleles

  2012cites this paper
• Genetic and Expression Analyses of the 'Nkrp1-Clr' Gene Cluster

  2012cites this paper
• Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells

  2012cites this paper
• The Role of Natural Killer Cells in Alzheimer’s Disease

  2012cites this paper
• The Role of NKR-P1B:Clr-b Recognition in NK Cell Mediated Immunity To Cytomegalovirus Infection

  2012influential citation
• Siglec-8 and Siglec-F, the new therapeutic targets in asthma

  2012influential citation
• The role of natural killer cells in autoimmune blistering diseases

  2012cites this paper